Formulations for parenteral administration of (e)-2,6-dialkoxystyryl 4-substituted benzylsulfones

Details for Australian Patent Application No. 2005265412 (hide)

Owner Onconova Therapeutics, Inc.

Inventors Maniar, Manoj; Bell, Staneley C.; Wong, Albert

Agent Fisher Adams Kelly

Pub. Number AU-B-2005265412

PCT Pub. Number WO2006/010152

Priority 60/589,075 19.07.04 US

Filing date 15 July 2005

Wipo publication date 26 January 2006

Acceptance publication date 2 September 2010

International Classifications

A61K 31/66 (2006.01) - Phosphorus compounds

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 31/325 (2006.01) - Carbamic acids

Event Publications

8 February 2007 PCT application entered the National Phase

  PCT publication WO2006/010152 Priority application(s): WO2006/010152

22 January 2009 Amendment Made

  The nature of the amendment is: Amend the invention title to read Formulations for parenteral administration of (e)-2,6-dialkoxystyryl 4-substituted benzylsulfones

2 September 2010 Application Accepted

  Published as AU-B-2005265412

6 January 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005265413-Lipid-amino acid conjugates and methods of use

2005265404-Injection of a radioactive dye for sentinel lymph node identification